Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	654.47	743.29	594.35	391.57	549.91	285.12
Short-Term Investments	-	-	-	-	-	231.45
Cash & Short-Term Investments	654.47	743.29	594.35	391.57	549.91	516.56
Cash Growth	30.78%	25.06%	51.79%	-28.79%	6.46%	97.07%
Accounts Receivable	-	-	-	-	-	0.03
Other Receivables	13.59	24.65	49.17	3.09	2.75	9.06
Total Trade Receivables	13.59	24.65	49.17	3.09	2.75	9.09
Other Current Assets	41.5	44.9	70.75	43.48	17.15	9.07
Total Current Assets	709.56	812.85	714.27	438.14	569.81	534.72
Net Property, Plant & Equipment	157.32	169.48	233.21	120.17	121.45	64.73
Other Intangible Assets	294.07	309.9	335.86	36.44	1.31	1.39
Goodwill	160.17	162.16	148.87	52.06	0.8	0.8
Other Long-Term Assets	18.4	19.74	16.39	6.89	7.92	8.72
Total Assets	1,340	1,474	1,449	653.7	701.29	610.35
Accounts Payable	20.35	18.12	21.61	3.95	4.59	2.82
Accrued Expenses	54.21	70.23	81.87	46.64	32.9	32.33
Short-Term Debt	9.27	9.09	8.43	0.04	0.1	0.09
Current Portion of Leases	13.09	12.66	13.8	6.12	5.95	-
Unearned Revenue	32.79	37.61	61.77	36.43	56.73	10
Other Current Liabilities	-	-	-	-	-	1.42
Total Current Liabilities	129.7	147.71	187.47	93.17	100.27	46.66
Long-Term Debt	7.18	9.56	19.02	1.1	0.54	0.63
Long-Term Leases	42.84	46.65	67.25	43.41	44.42	-
Other Long-Term Liabilities	135.03	139.35	140.07	52.58	70.26	20.12
Total Long-Term Liabilities	185.05	195.56	226.34	97.09	115.22	20.75
Total Liabilities	314.75	343.27	413.82	190.26	215.48	67.41
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-in Capital	3,192	3,170	2,474	1,431	1,125	943.14
Accumulated Other Comprehensive Income	26.66	36.72	-7.64	-	-	-0.13
Retained Earnings	-2,194	-2,076	-1,431	-967.62	-639.56	-400.08
Total Common Shareholders' Equity	1,025	1,131	1,035	463.44	485.81	542.94
Shareholders' Equity	1,025	1,131	1,035	463.44	485.81	542.94
Total Liabilities & Equity	1,340	1,474	1,449	653.7	701.29	610.35
Total Debt	72.38	77.97	108.49	50.67	51.01	0.72
Net Cash (Debt)	582.1	665.33	485.86	340.89	498.91	515.84
Net Cash Growth	-12.51%	36.94%	42.52%	-31.67%	-3.28%	106.63%
Net Cash Per Share	1.21	1.49	1.77	1.64	2.84	4.12
Book Value	1,025	1,131	1,035	463.44	485.81	542.94
Book Value Per Share	2.13	2.53	3.77	2.23	2.77	4.33
Tangible Book Value	570.53	658.8	550.05	374.94	483.7	540.75
Tangible Book Value Per Share	1.19	1.47	2.01	1.80	2.76	4.31

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q